[go: up one dir, main page]

EE200200348A - Ravimkoostis kasutamiseks valu ravis - Google Patents

Ravimkoostis kasutamiseks valu ravis

Info

Publication number
EE200200348A
EE200200348A EEP200200348A EEP200200348A EE200200348A EE 200200348 A EE200200348 A EE 200200348A EE P200200348 A EEP200200348 A EE P200200348A EE P200200348 A EEP200200348 A EE P200200348A EE 200200348 A EE200200348 A EE 200200348A
Authority
EE
Estonia
Prior art keywords
pain
treatment
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
EEP200200348A
Other languages
English (en)
Inventor
Alford Vernon
Michael Bare Thomas
Gordon Brown Dean
Marie Mclaren Frances
Murphy Megan
Ann Urbanek Rebecca
Xiao Wenhua
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200200348A publication Critical patent/EE200200348A/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/503—Pyridazines; Hydrogenated pyridazines spiro-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
EEP200200348A 1999-12-23 2000-12-19 Ravimkoostis kasutamiseks valu ravis EE200200348A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17190699P 1999-12-23 1999-12-23
US23683500P 2000-09-29 2000-09-29
PCT/SE2000/002605 WO2001047523A1 (en) 1999-12-23 2000-12-19 Method and composition for the treatment of pain

Publications (1)

Publication Number Publication Date
EE200200348A true EE200200348A (et) 2003-08-15

Family

ID=26867559

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200348A EE200200348A (et) 1999-12-23 2000-12-19 Ravimkoostis kasutamiseks valu ravis

Country Status (23)

Country Link
US (1) US20030162783A1 (et)
EP (1) EP1248621A1 (et)
JP (1) JP2003518499A (et)
KR (1) KR20020062983A (et)
CN (1) CN1434714A (et)
AR (1) AR027038A1 (et)
AU (1) AU783499B2 (et)
BG (1) BG106832A (et)
BR (1) BR0016646A (et)
CA (1) CA2394561A1 (et)
CO (1) CO5271687A1 (et)
EE (1) EE200200348A (et)
HK (1) HK1048767A1 (et)
HU (1) HUP0300043A3 (et)
IL (1) IL150202A0 (et)
IS (1) IS6428A (et)
MX (1) MXPA02006154A (et)
NO (1) NO20022990L (et)
NZ (1) NZ519389A (et)
PL (1) PL355850A1 (et)
RU (1) RU2238094C2 (et)
SK (1) SK8802002A3 (et)
WO (1) WO2001047523A1 (et)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1325004A1 (en) * 2000-09-29 2003-07-09 AstraZeneca AB 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain
DE60119949T2 (de) * 2000-09-29 2007-04-26 Astrazeneca Ab 1,2,5,10-TETRAHYDROPYRIDAZINOi4,5-BöCHINOLIN-1,10-DIONE UND IHRE ANWENDUNG IN DER BEHANDLUNG VON SCHMERZEN
AU2002214441A1 (en) * 2000-09-29 2002-04-08 Astrazeneca Ab 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain
SE0403172D0 (sv) * 2004-12-23 2004-12-23 Astrazeneca Ab Manufacturing process

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420590D0 (en) * 1993-10-22 1994-11-30 Zeneca Ltd Pyridazino quinoline compounds
US6730675B2 (en) * 1999-12-23 2004-05-04 Astrazeneca Ab Compounds and methods for the treatment of pain
JP2003519148A (ja) * 1999-12-23 2003-06-17 アストラゼネカ・アクチエボラーグ 痛みの処置のための化合物および方法
EP1244664A1 (en) * 1999-12-23 2002-10-02 AstraZeneca AB Compounds and methods for the treatment of pain

Also Published As

Publication number Publication date
EP1248621A1 (en) 2002-10-16
US20030162783A1 (en) 2003-08-28
NO20022990L (no) 2002-08-20
AR027038A1 (es) 2003-03-12
BG106832A (bg) 2003-03-31
HUP0300043A2 (en) 2003-05-28
RU2238094C2 (ru) 2004-10-20
PL355850A1 (en) 2004-05-31
NO20022990D0 (no) 2002-06-20
KR20020062983A (ko) 2002-07-31
AU2566001A (en) 2001-07-09
HK1048767A1 (zh) 2003-04-17
NZ519389A (en) 2004-05-28
CA2394561A1 (en) 2001-07-05
JP2003518499A (ja) 2003-06-10
IL150202A0 (en) 2002-12-01
SK8802002A3 (en) 2003-06-03
CN1434714A (zh) 2003-08-06
HUP0300043A3 (en) 2007-05-02
IS6428A (is) 2002-06-19
CO5271687A1 (es) 2003-04-30
MXPA02006154A (es) 2002-12-05
BR0016646A (pt) 2002-10-08
AU783499B2 (en) 2005-11-03
WO2001047523A1 (en) 2001-07-05

Similar Documents

Publication Publication Date Title
EE05073B1 (et) Retigabiin kasutamiseks neuropaatilise valu ravis
NO20022970L (no) Hydrogel-drevet medikamentdoseringsform
EE200100480A (et) Ksenoon kasutamiseks närvimürgistuste ravis
DK1204410T3 (da) Farmaceutisk doseringsform med flere komponenter
HUP0200831A3 (en) Novel pharmaceutical composition containing amoxycillin and its use
IL147217A0 (en) New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain
IL196301A0 (en) Medicament for the treatment of hapatitis c
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
HUP0203588A3 (en) Analgesic pharmaceutical compositions and their use
HUP0200879A2 (en) Pharmaceutical composition for dermal use
EE200200571A (et) Hüdroksüfenüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
GB0004167D0 (en) 1-piperidinyl-propan-2-ol derivatives and their use as therapeutic agents
DK1702618T3 (da) Brug af ET743 i kombinationsterapi med dexamethason til behandling af cancer
NO20005179D0 (no) Medikament behandling
ATE383868T1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
GB0003254D0 (en) Heterocyclic compounds and their therapeutic use
HUP0203121A3 (en) Pharmaceutical composition containing substituted benzimidazoles and its use
HUP0303236A3 (en) Carbamate compounds for use in the treatment of pain
EE200200577A (et) Kinolinüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
EE200200511A (et) Hüdroksüfenüülpiperasinüülmetüülbensamiidi derivaadid valu raviks
DE10081194D2 (de) Darreichungsform zur Applikation in Körperöffnungen
EE200200348A (et) Ravimkoostis kasutamiseks valu ravis
ID28817A (id) Penggunaan turunan-turunan tetrahidropiridin (atau4-hidropiperidin)-butilazol dalam pembuatan obat untuk perawatan nyeri
GB9904252D0 (en) Composition for the treatment of pain
HUP0300313A3 (en) Compound, pharmaceutical composition containing it and its use for the treatment of pain